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Kidney Res Clin Pract 31 (2012) A16–A96A76studied and received 1 nut (around 5g) a day for three months. The GSH-Px,
8-isoprostane, 8-OHdG, TNF-a and IL-6 levels were determined by ELISA before
and after supplementation. The LDL-c and HDL-c levels were determined by
enzymatic colorimetric method using the speciﬁc kit. After 3 months
supplementation, cytokines, 8-OHdG, 8-isoprostane levels decreased and the
activity of GSH-Px increased signiﬁcantly. Besides, after supplementation, the
HDL levels increased and LDL levels decreased signiﬁcantly.Parameters Before supplementation After supplementationGSH-Px (nmol/mL/min) 34.0675.2 40.378.4*8-isoprostane (pg/mL) 12.274.5 6.674.6*8-OHdG (pg/mL) 214.5(1.01042.0) 18.7 (1.078.8)*
IL-6 (pg/mL) 67.1 (21.180.2) 13.5 (12.822.2)*
TNF-a (pg/mL) 21.070.3 13.978.7*HDL (mg/dL) 39.0714.2 44.77 4.8*LDL (mg/dL) 86.0728.7 74.7729.5*n
po .0001The results indicate that one Brazilian nut per day is capable to improve
anti-inﬂammatory and antioxidant responses, and ameliorate lipids status
in HD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.556233
ASSOCIATION BETWEEN SELENIUM PLASMA LEVELS AND MUSCLE
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Selenium (Se) is a well-known antioxidant with a critical role in the proper
functioning of nervous and muscle functions. In the last decade, many authors
have suggested that Se may be a potent protective agent for neurons and
myocytes through selenoprotein expression in the brain, as well as in skeletal
and cardiac muscles. Low Se status has been associated with reduced
coordination, motor speed and muscle strength. Reduced muscle function is
common in hemodialysis (HD) patients; however, no study evaluated the
association betweenmuscle function and Se levels in HD patients. The objective
of this study was to correlate muscle function with Se plasma levels in HD
patients. Twenty HD patients (12 men, 54.5715.2 yr; 81.7752.8 months on
HD) from RenalCor Clinic at Rio de Janeiro, Brazil were studied. Blood samples
were collected during fasting, before a regular HD session. The Se plasma levels
were determined by atomic absorption spectrophotometry with hydride
generation (Hitachi, Z-500) and handgrip strength (HGS) was measured three
times with a mechanical dynamometer (Jamar) after HD sessions in the non-
ﬁstula side and the highest value was used for analysis. HGS values less than
the 10th percentile of an age-, gender- and regional speciﬁc reference were
considered as muscle function loss. Plasma Se levels (31.9714.8 mg/L) were
below the normal range (60-120 mg/L) and all patients were Se deﬁcient. HGS
values were signiﬁcantly greater in males (31.0711.5 kg vs 14.076.8 kg for
females) (p¼0.001) and the muscle function loss was observed in 50% of
patients and, those with muscle function loss presented low Se levels
(26.5712.1 mg/L) when compared to patients with preserved muscle function
(39.12714.5 mg/L) (p¼0.05). These data suggest that Se can have an important
role on muscle function in HD patients. However, more research is needed to
better understand this possible relationship in CKD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.557234
IS SELENIUM STATUS ASSOCIATED WITH MORTALITY RISK IN
HEMODIALYSIS PATIENTS?
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Previous studies have indicated selenium (Se) deﬁciency in hemodialysis
(HD) patients and it may increase the mortality risk for death among
hemodialysis patients. Studies from our laboratory showed poor
nutritional status of Se in HD patients. The purpose of this study was to
evaluate Se levels as predictors of cardiovascular mortality in HD patients.
A total of 44 HD patients (53.0715.0 years old, average time on dialysis
80.17112.7 months, BMI, 24.6734.3 kg/m2) from the RenalCor Clinic in
Rio de Janeiro, Brazil, were followed up 36 months. The plasma anderythrocyte Se levels were determined by atomic absorption
spectrophotometry with hydride generation (Hitachi, Z500). Associations
between Se levels and cardiovascular mortality in HD patients were
examined by Cox’s regression model. Mean plasma Se was 72.1770.1 mg/L
and erythrocyte Se 194.87148.91 mg/L and a total of 17 patients died from
cardiovascular event during the follow-up period. Analysis by the Cox
model showed that only low erythrocyte Se levels were signiﬁcant
predictors of mortality (hazard ratio [HR] 0.995 [95% CI 0.991-0.999]. In
conclusion, decreased erythrocyte Se level may increase the risk of death in
hemodialysis patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.558235
IS PROTEIN-ENERGY INTAKE ADEQUATE DURING DIALYSIS TREATMENT
IN HEMODIALYSIS PATIENTS ?
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J.M. Weijs
Nutrition & Dietetics, Internal Medicine VU University Medical Centre,
Amsterdam, the Netherlands
Protein-energy wasting (PEW) is a strong predictor of mortality in patients
with chronic kidney disease. Although PEW is caused by non nutritional
conditions, research indicates that nutritional support that targets adequate
protein intake improves outcome. During dialysis therapy in-centre meals and
snacks are provided. The question is whether these meals provide adequate
protein and energy intake considering external (at home) consumed meals?
Indirect calorimetry and physical activity Level (PAL) were performed to
provide daily energy needs. Three day food record was performed for 2 dialysis
days and 1 non dialysis day. Statistical analysis was done using SPSS19, paired
T-test was used to detect signiﬁcant differences (po0.05). Mean and standard
deviations are given.
In the VU University Medical Centre 20 hemodialysis patients (12 men),
mean age 5873 year, BMI (kg/m2) 2676 were enrolled.
Results: Protein intake was 82% of protein requirements (68þ21 vs 83þ12
g/d, po0.001). Energy intake was 87% of energy requirements (1636þ483
vs 18787244 kcal/d, po0.001). Protein intake on dialysis days was
72719 vs 65729 g/d on non-dialysis days (po0.142). Energy intake on
dialysis days was 17867486 vs 15707609 kcal/d on non-dialysis days
(po0.031). Dinner or lunch provided 39% of the daily energy needs, which
is adequate according to a national guideline; and 35% of daily protein
needs, which is lower than healthy Dutch adults.
Conclusion: Protein and energy intake of hemodialysis patients is lower
than their daily needs. On non dialysis days intake is even lower than on
dialysis days. The meals consumed during dialysis treatment contain
enough energy but not enough protein to meet requirements.
http://dx.doi.org/10.1016/j.krcp.2012.04.559
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RESTING ENERGY EXPENDITURE IN HEMODIALYSIS PATIENTS: WHICH
PREDICTION EQUATION ESTIMATES THE BEST?
Trudeke (G) I. Struijk-Wielinga, Peter J.M. Weijs
Nutrition & Dietetics, Internal Medicine VU University Medical Centre,
Amsterdam, the Netherlands
In chronic kidney disease (CKD) there are many metabolic changes that can
inﬂuence resting energy expenditure (REE). Protein energy wasting is highly
prevalent in hemodialysis patients. Estimating REE is the ﬁrst step in the
process to advise an adequate nutritional therapy. There are many prediction
equations for REE. The purpose of this study is to determine which equation
predicts REE in a reliable way. In the VU University Medical Centre 56
hemodialysis patients (33 men), mean age 56714.8 year, BMI (kg/m2)
27.076 indirect calorimetry was performed. Measured REE was compared
with sixteen different prediction equations based on weight, height, sex, and/
or age. The Root Mean Squared prediction Error (RMSE) are presented as well
as the average difference between estimation and measurement (bias). 90–
110% adequacy of measured REE was accepted as accurate prediction.
The measured REE was 15267299 kcal/d (mean7SD). The percentage
accurate predictions, percentage bias and RMSE were: for original Harris
Benedict equation (1919), Schoﬁeld equation based on weight and height and
Cole equation respectively 48%, 50%, 57%; bias: þ2.9%, þ4.4%, -0.5%; RMSE:
288, 286,271 kcal/d.
Conclusion: In this study Coles prediction equations provide an acceptable
estimate of resting energy expenditure of HD patients. Further insight into
explaining factors is warranted.
